Abstract
myo‐Inositol causes no disruption in the growth‐inhibiting effect of the phos‐phatidylinositol (Ptdlns) derivative 1. This first synthetic Ptdlns analogue with a myo‐inositol configuration may point the way to new anti‐cancer agents based on the interruption of Pdtlns signaling, which do not inhibit cell growth by interaction with DNA. (Figure Presented.)
Original language | English (US) |
---|---|
Pages (from-to) | 1379-1381 |
Number of pages | 3 |
Journal | Angewandte Chemie International Edition in English |
Volume | 31 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1992 |
Externally published | Yes |
ASJC Scopus subject areas
- Catalysis
- General Chemistry